Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.
Andrea GabrioNecdet B GunsoyGianluca BaioAlan A MartinVictoria Federico PalyNancy RisebroughDavid M G HalpinDave SinghRobert A WiseMeiLan K HanFernando J MartinezGerard J CrinerNeil MartinDavid A LipsonAfisi S IsmailaPublished in: International journal of chronic obstructive pulmonary disease (2022)
PPPY rates were typically lower with FF/UMEC/VI versus FF/VI or UMEC/VI.